Neurology® Podcast cover image

Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine

Neurology® Podcast

00:00

Is This a Drug That Should Be Dosed and to a Patient After Receiving a Prescription?

The accelerator approvel requires a further study to validate the actual relationship between lowering amaloid using this drug and clinical benefit. How that study will be done now, if the drugs out there commercially remains a conundrum. And its vant honor to interviewed r kaiser, a neuralogist otheheading specialist at the university of pennsylvania,. about his article, reflextive eye closure in response to cone and met nopson stimulation.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app